Medtronic’s Right Ventricular Lead Gets Japanese Go Ahead
December 17, 2007 – Medtronic today announced it received Japanese regulatory approval on December 10, 2007 for the Sprint Quattro (Model 6944 and 6947) steroid-eluting right ventricular lead used with implantable cardioverter-defibrillators (ICDs) that detect and treat rapid heart rhythms, representing Japan’s first 8.6 French defibrillation lead to feature screw-in fixation.
The Sprint Quattro 6947 has bipolar sensing and dual coil defibrillation. Screw-in fixation offers flexibility in securing the ICD lead in various right ventricle locations. The company hopes to receive reimbursement for Sprint Quattro by January 1, 2008, which then would allow for its immediate commercial launch in Japan.
Previously approved and used in Europe and the United States since 2001, the Sprint Quattro 6947 Screw-In ICD lead is used with various ICD and cardiac resynchronization therapy (CRT) devices such as the Medtronic Concerto CRT-D, and the Virtuoso VR ICD, both of which were introduced in Japan in July 2007.
For more information: www.medtronic.com
More like this
- Medtronic Gets FDA Clearance for Sprint Quattro Secure S Single Coil Defibrillation Lead
- Medtronic Suspends Distribution of Defibrillation Leads
- FDA Clears Medtronic’s DF4 High-Voltage ICD, CRT Connector System
- Data From 100,000 ICDs Show Battery Longevity Projections of 9-13 Years
- St. Jude, Medtronic Battle Over ICD Leads